HIGHLIGHTS
- who: Stefania Kokkali et al. from the Department of Medical Oncology, Saintu2011Savvas Anticancer Hospital, Athens, Greece Kapodistrian University of Athens, Athens, Greece have published the research work: Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers, in the Journal: (JOURNAL) of 31/01/2023
- what: The study demonstrates that cabozantinib has antitumor activity in this population. The study provides realu2011world data on the effectiveness and safety of the antiu2011angiogenic agent cabozantinib for advanced OS and ES cases, and further supports the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.